1066

Dr Snita Sinukumar

Oncology Surgical Oncology • 
11+ Years  experience
MBBS, MS, MCh ( Surgical Oncology), Fellowship (Peritoneal Surface Malignancy & HIPEC)
10:00 - 15:00  •  MON - SAT English  •  Hindi  •  Marathi  •  Bengali

DOCTOR UNAVAILABLE

No Slots Available. Please request a call back

Select Date

    > Loading available days...

Available Slots:

    Overview

    Dr. Snita Sinukumar is a dedicated Surgical Oncologist at Apollo Hospitals, Pune, with over 11 years of experience in the field of cancer surgery. She holds an MBBS, MS, MCh in Surgical Oncology, along with an esteemed ESPSO Fellowship in Peritoneal Surface Malignancy & HIPEC from IRCC Fondazione, National Cancer Institute, Milan, Italy. Her expertise includes advanced oncological procedures, with a special focus on HIPEC (Hyperthermic Intraperitoneal Chemotherapy) and peritoneal surface malignancies.

    Fluent in English, Hindi, Marathi, and Bengali, Dr. Sinukumar ensures effective communication with her patients and their families, guiding them with clarity and compassion through every stage of their cancer journey. Her patient-first approach emphasizes not just treatment, but also emotional support and empowerment, helping patients make informed decisions with confidence.

    At Apollo, Dr. Sinukumar combines her international training and advanced surgical skills with the latest medical technologies to provide comprehensive, personalized cancer care. Recognized for her precision, dedication, and collaborative approach, she works closely with multidisciplinary teams to achieve the best outcomes. Dr. Snita Sinukumar is regarded as a trusted name in surgical oncology, committed to delivering expert, compassionate care that transforms lives.

    Apollo Hospitals, Pune
    Apollo Hospitals Enterprise Limited, Plot 127A, Shankar Sheth Road, Swargate, Pune, Maharashtra , pune, MH, 411042

    Experience

    • Sr. Registrar (Surgical Oncology) – TATA Memorial Hospital
    • Fellow in Breast Oncology – TATA Memorial Hospital
    • Special Registrar (Surgical Oncology) – TATA Memorial Hospital
    • Consultant (Surgical Oncologist and HIPEC Specialist) – Jehangir Hospital, Pune

    Memberships

    • Indian Association of Surgical Oncologist (IASO),
    • Member, Association of Robotic surgeons of India (ARIS)
    • Member, International Society of peritoneal surface oncology group (PSOGI)
    • Member, Society of peritoneal surface oncology of India. SPSOI

    Awards

    • "Best Abstract Award" for "Pattern of recurrence after cytoreductive surgery and HIPEC following neoadjuvant chemotherapy in primary advanced stage IIIC/IVA epithelial ovarian cancer" at the 12th international PSOGI conference, Sept 10th-13th, 2021

    • Awarded The '3rd Surabhi Nag Research Awards 2018', with a grant of Rs 600,000/- for the clinical proposal entitled: 'Total Parietal Peritonectomy in patients with advanced ovarian cancer after neoadjuvant chemotherapy'

    • Best Poster at PSOGI, Paris, Sept 2018: "Failure-to-Rescue Following Cytoreductive Surgery with or Without HIPEC is Determined by the Type of Complication" – a Retrospective Study by INDEPSO

    • Won the Poster of Distinction for "Clinical Outcomes of Patients Undergoing Laparoscopic vs Open Surgery for Rectal Cancers" at the DDF, London, U.K., 2015

    • Won the Award for Outstanding Paper for "A Comparative Study between Prolene Mesh and Indigenous Mosquito Net for Inguinal Hernia Repair" at the 52nd Annual Conference of the International College of Surgeons – Indian Section, Cidade Goa, Oct 7th, 2006

    • Won the Ratan Tata Scholarship for the academic year 2006-2007

    • Won the B.Braun Award for "Meritorious Student" in General Surgery for the academic year 2006-2007

    Research and Publication

    Publications and Citations:

    • Several publications in national and international journals

    • Over 800 citations

    Recent Publications:

    1. Sinukumar S, Kammar P, Ray M, Shaikh S, Patel A, Rajan F, et al. Long-term Survival in Patients Treated by Cytoreductive Surgery with or without HIPEC for Peritoneal Surface Malignancies – A report from the Indian HIPEC Registry. Indian J Surg Oncol. 2023 Jun;14(Suppl 1):198-208. doi:10.1007/s13193-023-01727-7. PMID: 37359912; PMCID: PMC10284732.

    2. Sinukumar S, Damodaran D, Ray M, Prabhu A, Katdare N, et al. Cytoreductive Surgery With or Without HIPEC in Peritoneal Dissemination from Rare Histological Subtypes of Ovarian Cancer – Retrospective Study by INDEPSO. Indian J Surg Oncol. 2023 Jun;14(Suppl 1):74-81. doi:10.1007/s13193-022-01640-5. PMID: 37359936; PMCID: PMC10284742.

    3. Sinukumar S, Damodaran D, Ray M, Mehta S, Paul L, Bhatt A. Pattern of recurrence after interval cytoreductive surgery and HIPEC following neoadjuvant chemotherapy in primary advanced stage IIIC/IVA epithelial ovarian cancer. Eur J Surg Oncol. 2021 Jun;47(6):1427-1433. doi:10.1016/j.ejso.2021.01.013. PMID: 33509612.

    4. Bhatt A, Kammar P, Sinukumar S, et al. Total Parietal Peritonectomy Can Be Performed with Acceptable Morbidity for Advanced Ovarian Cancer After Neoadjuvant Chemotherapy: Results From a Prospective Multi-centric Study. Ann Surg Oncol. 2021 Feb;28(2):1118-1129. doi:10.1245/s10434-020-08918-4. PMID: 32748154.

    5. Sinukumar S, Naik S, Khurjekar D, et al. Pancreaticopleural Fistula After Cytoreductive Surgery and HIPEC for Pseudomyxoma Peritonei – Rare Presentation. Indian J Surg Oncol. 2020 Sep;11(Suppl 2):174-177. doi:10.1007/s13193-020-01149-9. PMID: 33364691; PMCID: PMC7732892.

    6. Sinukumar S, Rajan F, Mehta S, et al. Outcomes Following Total vs Selective Peritonectomy During Interval Cytoreductive Surgery for Advanced Serous Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer – INDEPSO Study. Eur J Surg Oncol. 2021 Jan;47(1):75-81. doi:10.1016/j.ejso.2019.02.031. PMID: 30857879.

    7. Sikora TM, Sinukumar S, Naik S, et al. Rare Case of Metachronous Gastric Metastasis from Primary Ovarian Carcinoma. Indian J Surg Oncol. 2024. 

    8. Sinukumar S, Mehta S, Damodaran D, et al. Failure-to-Rescue Following Cytoreductive Surgery with or Without HIPEC is Determined by Type of Complication – Retrospective Study by INDEPSO. Indian J Surg Oncol. 2019 Feb;10(Suppl 1):71-79. doi:10.1007/s13193-019-00877-x. PMID: 30886497; PMCID: PMC6397122.

    Special Interests

    • Peritoneal Surface Malignancy
    • Breast Surgery
    • Gastrointestinal (GI) and Gynecologic Oncology
    • Robotic Surgery

    Could not find what you are looking for? 

    Request a Callback

    Image
    Image
    Request A Call Back
    Request Type